China Drugmaker Plunges After Wanda Director Doubts Covid Treatment Efficacy
The stock price of traditional Chinese medicine-maker Yiling Pharmaceutical plunged after Wang Sicong, founder of Prometheus Capital and director of Wanda Group, reposted a video on April 14 on Weibo that questioned whether the World Health Organization had ever recommended the firm’s Lianhua Qingwen capsules as Covid-19 treatm…
Keep reading with a 7-day free trial
Subscribe to Pandaily to keep reading this post and get 7 days of free access to the full post archives.